Affirming the Value of Clinical Chemotherapy Pathways Programs

JCO Oncol Pract. 2021 Aug;17(8):463-464. doi: 10.1200/OP.21.00448. Epub 2021 Jul 15.

Authors

J Russell Hoverman¹, Aimee Ginsburg², Lalan Wilfong¹, Marcus Neubauer²

Affiliations

¹ Texas Oncology, Dallas, TX.
² McKesson Specialty Health, The Woodlands, TX.

PMID: 34264773
DOI: 10.1200/OP.21.00448

No abstract available

Publication types

Editorial
Comment

MeSH terms

Critical Pathways
Gender Identity
Humans
Transgender Persons*